The Gap Junction Group

The research focus of the Gap Junction Group is the regulation of cardiac conduction. We are particularly interested in the role of gap junctions and their use as anti-arrhytmic target.

The work of the Gap Junction Group has contributed to the demonstration that the drug candidate rotigaptide enhanced gap junctional coupling, prevented conduction slowing, reduced rather than increased infarct size and that rotigaptide acted by preventing Cx43 de-phosphorylation.





























Group Leader Morten Schak Nielsen

Group Leader
Morten Schak Nielsen 
Associate Professor

Phone +45 3532 7427

Group/project members

Internal researchers

Name Title Phone E-mail
Kristoffer Racz Laboratory Technician +4535330725 E-mail